Form 4: Calix CPO Sells Shares After Option Exercise

Calix Chief Product Officer Shane Eleniak exercised stock options and subsequently sold 24,000 shares of common stock for a significant gain.

Summary

• Shane Eleniak, Chief Product Officer of Calix, Inc. (CALX), engaged in an equity transaction on November 10, 2025.
• Eleniak exercised stock options to acquire 24,000 shares of Calix common stock at an exercise price of $8.03 per share.
• Immediately following the option exercise, Eleniak sold all 24,000 shares of common stock.
• The shares were sold at a weighted average price of $64.135 per share, with individual sales ranging from $64.00 to $64.295.
• The stock options were fully vested and exercisable on February 14, 2023, and had an expiration date of February 14, 2029.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 6

Explanation: The transaction reflects a significant profit for the insider, indicating past stock performance, but is a routine insider sale under a 10b5-1 plan, making its overall sentiment impact neutral to slightly positive.

Positives

• The transaction demonstrates a significant personal gain for the Chief Product Officer, as the sale price of $64.135 per share is substantially higher than the exercise price of $8.03 per share.
• The use of a Rule 10b5-1 plan indicates a pre-scheduled transaction, which can mitigate concerns about opportunistic insider trading.

Negatives

• An insider sale, even if pre-arranged, reduces the direct equity stake of a key executive in the company, which some investors might interpret as a lack of conviction, though this is often a routine liquidity event.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is specific to Calix, Inc. and its Chief Product Officer and does not directly relate to broader industry trends or competitor performance, beyond reflecting the general market conditions that allowed for the stock's appreciation.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the transaction as a routine liquidity event for an executive, especially given the 10b5-1 plan, and it reflects the stock's appreciation, which is generally positive. However, some might note the reduction in direct insider ownership.

Key Dates

Recommendation

A single Form 4 filing detailing a pre-arranged insider sale, even by a Chief Product Officer, typically does not provide sufficient new fundamental information to warrant a change in investment recommendation. The transaction appears to be a planned liquidity event rather than a signal of a change in the company's prospects.

Keywords

CALX, Calix, insider transaction, Form 4, stock option exercise, share sale, Chief Product Officer, Shane Eleniak, equity compensation, 10b5-1 plan